Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine Congress

image

Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine Congress – Nanotechnology News Today – EIN Presswire

Trusted News Since 1995

A service for nanotechnology industry professionals
·
Wednesday, October 19, 2022

·
596,741,246
Articles


·
3+ Million Readers

News Monitoring and Press Release Distribution Tools

News Topics

Newsletters

Press Releases

Events & Conferences

RSS Feeds

Other Services

Questions?

Peyman Taeidi

Leave a Reply

Your email address will not be published. Required fields are marked *